Literature DB >> 12867434

Viral vascular endothelial growth factors vary extensively in amino acid sequence, receptor-binding specificities, and the ability to induce vascular permeability yet are uniformly active mitogens.

Lyn M Wise1, Norihito Ueda, Nicola H Dryden, Stephen B Fleming, Carol Caesar, Sally Roufail, Marc G Achen, Steven A Stacker, Andrew A Mercer.   

Abstract

Infections of humans and ungulates by parapoxviruses result in skin lesions characterized by extensive vascular changes that have been linked to viral-encoded homologues of vascular endothelial growth factor (VEGF). VEGF acts via a family of receptors (VEGFRs) to mediate endothelial cell proliferation, vascular permeability, and angiogenesis. The VEGF genes from independent parapoxvirus isolates show an extraordinary degree of inter-strain sequence variation. We conducted functional comparisons of five representatives of the divergent viral VEGFs. These revealed that despite the sequence divergence, all were equally active mitogens, stimulating proliferation of human endothelial cells in vitro and vascularization of sheep skin in vivo with potencies equivalent to VEGF. This was achieved even though the viral VEGFs bound VEGFR-2 less avidly than did VEGF. Surprisingly the viral VEGFs varied in their ability to cross-link VEGFR-2, induce vascular permeability and bind neuropilin-1. Correlations between these three activities were detected. In addition it was possible to correlate these functional variations with certain sequence and structural motifs specific to the viral VEGFs. In contrast to the conserved ability to bind human VEGFR-2, the viral growth factors did not bind either VEGFR-1 or VEGFR-3. We propose that the extensive sequence divergence seen in the viral VEGFs was generated primarily by selection against VEGFR-1 binding.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12867434     DOI: 10.1074/jbc.M301194200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Angiogenesis in fatal acute Kawasaki disease coronary artery and myocardium.

Authors:  A F Freeman; S E Crawford; M L Cornwall; F L Garcia; S T Shulman; A H Rowley
Journal:  Pediatr Cardiol       Date:  2005 Sep-Oct       Impact factor: 1.655

2.  Structural determinants of growth factor binding and specificity by VEGF receptor 2.

Authors:  Veli-Matti Leppänen; Andrea E Prota; Michael Jeltsch; Andrey Anisimov; Nisse Kalkkinen; Tomas Strandin; Hilkka Lankinen; Adrian Goldman; Kurt Ballmer-Hofer; Kari Alitalo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-09       Impact factor: 11.205

3.  The propeptides of VEGF-D determine heparin binding, receptor heterodimerization, and effects on tumor biology.

Authors:  Nicole C Harris; Natalia Davydova; Sally Roufail; Sophie Paquet-Fifield; Karri Paavonen; Tara Karnezis; You-Fang Zhang; Teruhiko Sato; Julie Rothacker; Edouard C Nice; Steven A Stacker; Marc G Achen
Journal:  J Biol Chem       Date:  2013-02-12       Impact factor: 5.157

4.  Snake venom Vascular Endothelial Growth Factors (VEGF-Fs) exclusively vary their structures and functions among species.

Authors:  Yasuo Yamazaki; Yukiko Matsunaga; Yuko Tokunaga; Shinya Obayashi; Mai Saito; Takashi Morita
Journal:  J Biol Chem       Date:  2009-02-10       Impact factor: 5.157

5.  A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors.

Authors:  Steven A Stacker; Michael M Halford; Sally Roufail; Carol Caesar; Marc G Achen
Journal:  J Vis Exp       Date:  2016-03-15       Impact factor: 1.355

6.  VEGF Receptor-2 Activation Mediated by VEGF-E Limits Scar Tissue Formation Following Cutaneous Injury.

Authors:  Lyn M Wise; Gabriella S Stuart; Nicola C Real; Stephen B Fleming; Andrew A Mercer
Journal:  Adv Wound Care (New Rochelle)       Date:  2018-08-01       Impact factor: 4.730

Review 7.  Lymphovascular and neural regulation of metastasis: shared tumour signalling pathways and novel therapeutic approaches.

Authors:  Caroline P Le; Tara Karnezis; Marc G Achen; Steven A Stacker; Erica K Sloan
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2013-10-15

8.  Infectious spleen and kidney necrosis virus ORF48R functions as a new viral vascular endothelial growth factor.

Authors:  Zi-Liang Wang; Xiao-Peng Xu; Bai-Liang He; Shao-Ping Weng; Jia Xiao; Li Wang; Ting Lin; Xi Liu; Qing Wang; Xiao-Qiang Yu; Jian-Guo He
Journal:  J Virol       Date:  2008-02-27       Impact factor: 5.103

9.  VEGF-A is necessary and sufficient for retinal neuroprotection in models of experimental glaucoma.

Authors:  Richard H Foxton; Arthur Finkelstein; Sauparnika Vijay; Annegret Dahlmann-Noor; Peng T Khaw; James E Morgan; David T Shima; Yin-Shan Ng
Journal:  Am J Pathol       Date:  2013-02-12       Impact factor: 4.307

10.  Proteomic characterization of HIV-modulated membrane receptors, kinases and signaling proteins involved in novel angiogenic pathways.

Authors:  Suraiya Rasheed; Jasper S Yan; Adil Hussain; Bruce Lai
Journal:  J Transl Med       Date:  2009-08-27       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.